Entering Yangzhou Fluorine Medicine

Created a new field of research and development for new fluorinated drugs and fluorinated pharmaceutical intermediates in China

 

Yangzhou Fluorine Pharmaceutical Technology Co., Ltd. was founded in 2011 by a second prize winner of the National Natural Science Award, a team of innovative talents from Jiangsu Province, and multiple overseas returnee doctoral teams. It is a leading fluorine containing pharmaceutical technology company in China. The company focuses on the research and development of fluorinated pharmaceutical products and their process technologies, including fluorinated new drugs and intermediate products. Products and technologies are distributed in various stages of the pharmaceutical value chain: preclinical new drug development stage; Clinical stages I, II, and III; Research and development, preparation, sales, and technology transfer of rare heterocyclic structures and fluorinated new drug templates for products in the marketing stage. The main products that the company currently develops and matures are world advanced and leading products. In the research and development of fluorinated pharmaceutical products, we use our self-developed fluorinated block technology to replace fluorination technology, achieving industrialization of the products and enhancing our competitive position. At present, the company has multiple world-leading core patented technologies. The company's short-term and medium-term goal is to continue to develop world-class fluorinated pharmaceutical products and technologies, and expand market share. The long-term goal of the company is to develop non patented drugs based on fluorine atoms and new fluorinated drugs.[View details]

Enterprise Display

It has created a new field of research and development of fluorine-containing new drugs and fluorine-containing pharmaceutical intermediates in China
Conference room
Corporate environment
Office area
Laboratory environment
Research and development laboratory
Laboratory environment
Laboratory equipment

News Center

It has created a new field of research and development of fluorine-containing new drugs and fluorine-containing pharmaceutical intermediates in China
The company has launched its new website

The company has launched its new website

4-10
2023 year
Congratulations on the successful project of "Shanghai Green Fluoropharmaceutical Engineering Technology Research Center" jointly established by Aqikang Medical Science and Technology and Shanghai University of Applied Technology!

Congratulations on the successful project of "Shanghai Green Fluoropharmaceutical Engineering Technology Research Center" jointly established by Aqikang Medical Science and Technology and Shanghai University of Applied Technology!

4-6
2023 year
Whole process antibody drug research and development - help biological drug IND declaration

Nucleic acid drugs are drugs that use the translation or regulation function of nucleic acid molecules to intervene in diseases. Compared with traditional small molecule drugs and antibody drugs, nucleic acid drugs can intervene at the source, inhibit the expression of disease-related genes into pathological proteins, or introduce genes that can express normal proteins.

4-6
2023 year
View Details
No content!